L3Harris Technologies, Inc. (LHX) has a notice of proposed sale filed under Rule 144 for common stock held for the benefit of officer Christopher Kubasik. The notice covers planned sales totaling 21,916 shares of common stock through Goldman Sachs & Co. LLC as broker.
The securities to be sold were acquired as compensation through multiple Restricted Stock Unit grants from 2018 and 2019, including awards dated December 14, 2018 and June 29, 2019. The filing states that 7,411 shares are to be sold by KUBASIK, C GRAT BKG 2025 1.0 and 14,505 shares by KUBASIK, C GRAT BKG 2024 5.0.
It discloses a planned resale of 21,916 L3Harris (LHX) common shares for the account of officer Christopher Kubasik under Rule 144, with Goldman Sachs & Co. LLC acting as broker and the shares originally acquired as compensation via Restricted Stock Units.
The filing states that 7,411 shares are to be sold by KUBASIK, C GRAT BKG 2025 1.0 and 14,505 shares are to be sold by KUBASIK, C GRAT BKG 2024 5.0, together accounting for the 21,916 shares covered by the notice.
The common shares to be sold were acquired as compensation through several Restricted Stock Unit grants from L3Harris Technologies, Inc., including grants dated December 14, 2018, February 11, 2019, February 16, 2019, and June 29, 2019.
The planned sales of L3Harris (LHX) common stock are to be handled by Goldman Sachs & Co. LLC, listed with its New York address, as the broker in the Form 144 securities information section.
The securities information section lists an aggregate market value of 5,443,276.92 for the L3Harris common stock covered by the notice, along with 186,214,616 shares shown as outstanding for the issuer.
The notice is dated September 10, 2026, which appears both as the date in the securities information section and as the Date of Notice in the remarks and signature portion of the filing.
https://www.sec.gov/Archives/edgar/data/202058/000195824426000587/xsl144X01/primary_doc.xml